MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$49,128K
Net Income
-$8,908K
Net Profit Margin
-18.13%
EPS
-$0.03
Unit: Thousand (K) dollars
Revenue Breakdown
Auryxia
Vafseo
Japan Tobacco Incorporation And ...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
49,128
53,544
57,622
58,766
Cost of product and other revenue
10,424
12,290
12,535
9,383
Amortization of intangible asset
-
-
0
0
Total cost of goods sold
10,424
12,290
12,535
9,383
Research and development
14,059
14,807
26,648
14,944
Selling, general and administrative
28,171
30,436
26,089
29,094
License
855
707
903
896
Restructuring
1,945
-
0
0
Total operating expenses
45,030
45,950
53,640
44,934
Income (gain) from operations
-6,326
-4,696
-8,553
4,449
Interest expense
-3,071
-4,691
-4,827
-4,748
Other income (expense)
-7
3
-117
-10
Change in fair value of warrant liability
-566
-456
-2,262
-1,464
Loss on extinguishment of debt
-
-
0*
0
Loss on termination of lease
-
-
0*
-
Income (loss) before income taxes
-8,838
-8,928
-11,235
1,155
Income tax expense
70
126
1,009
615
Net income (loss)
-8,908
-9,054
-12,244
540
Comprehensive income (loss)
-8,908
-9,054
-12,244
540
Basic EPS
-0.03
-0.03
-0.046
0
Diluted EPS
-0.03
-0.03
-0.051
0
Basic Average Shares
269,602,747
267,046,755
265,781,476
264,786,432
Diluted Average Shares
269,602,747
267,046,755
241,551,533
274,372,722
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive income (loss)
-$8,908K
(-3706.48%↓ Y/Y)
Net income (loss)
-$8,908K
(-3706.48%↓ Y/Y)
Auryxia
$25,463K
Vafseo
$21,302K
Japan Tobacco
Incorporation And Torii...
$1,424K
MEDICEArzneimittel Putter Gmb HCo KG
$527K
Tanabe Pharma
Corporation
$412K
Income (loss) before
income taxes
-$8,838K
(-3678.14%↓ Y/Y)
Income tax expense
$70K
Change in fair value of
warrant liability
-$566K
(-108.11%↓ Y/Y)
Product
$46,765K
(-22.65%↓ Y/Y)
License Collaboration
And Other Revenue
$2,363K
(17.50%↑ Y/Y)
Income (gain) from
operations
-$6,326K
(-144.90%↓ Y/Y)
Interest expense
-$3,071K
(55.06%↑ Y/Y)
Total revenues
$49,128K
(-21.36%↓ Y/Y)
Other income
(expense)
-$7K
(75.00%↑ Y/Y)
Total operating
expenses
$45,030K
(17.07%↑ Y/Y)
Total cost of goods
sold
$10,424K
(5.09%↑ Y/Y)
Selling, general and
administrative
$28,171K
(6.09%↑ Y/Y)
Research and development
$14,059K
(27.66%↑ Y/Y)
Restructuring
$1,945K
License
$855K
(-4.58%↓ Y/Y)
Cost of product and
other revenue
$10,424K
(5.09%↑ Y/Y)
Buy us a coffee
Akebia Therapeutics, Inc. (AKBA)
Akebia Therapeutics, Inc. (AKBA)